TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06127199: Contraceptive Efficacy Study of Ovaprene

Sponsor: Daré Bioscience, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 656 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$1,095,600

Rescue Site Savings

+$730,400

Unlock Full NCT06127199 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06127199 Rescue Dossier →